New York, NY, November 20, 2009-Ebitda News reports that negative EBITDA for Neurogen Corporation (NASDAQ:NRGN) for its quarter ended September 30, 2009 was $(2,110,000), a 74% improvement over the ye ... read full story
U.S. markets ended a choppy session with modest gains as investors awaited news regarding a Greek austerity deal. It remains unclear whether Greek Prime Minister Lucas Papademos can get politicians to accept the tough austerity policies. According to ... read full story